Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06920563

Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education

The goal of this clinical trial is to learn if patient education and regular text reminders are a feasible intervention to engage patients and reduce post partum hypertension. The main questions it aims to answer are:

Is a structured postpartum remote blood pressure monitoring intervention with education and individualized medication initiation/adjustment follow-up by televisit feasible? Does a structured program reduce the occurrence of postpartum hypertension, ED visits, hospital readmissions, and adverse outcomes?

Participants will:

View an educational video on HDP post-delivery Receive 1-2 times daily text messages for 6 weeks postpartum Have their blood pressure medications adjusted to lower targets post partum

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Pre-Eclampsia; Complicating Pregnancy Cardiovascular Diseases Female Urogenital Diseases and Pregnancy Complications Gestational Hypertension Hypertension Hypertension, Pregnancy-Induced Pre-Eclampsia Pregnancy Complications Urogenital Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Ochsner Baptist

New Orleans, Louisiana, 70115, United States

Location status: Recruiting

Location contact

Daniel Morin, MD

SUB_INVESTIGATOR

Frank Williams, MD

SUB_INVESTIGATOR

Keira Barker, MD

SUB_INVESTIGATOR

Ken Bode

CONTACT

[email protected]

+1 (504) 842-1936

Koyenum Obi, MD

SUB_INVESTIGATOR

Salima Qamruddin

PRINCIPAL_INVESTIGATOR

Talia Suner, MD

SUB_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age of at least 18 years.
  • Postpartum status.
  • Experience new-onset hypertension during pregnancy.
  • Enrollment in Connected MOM.
  • Ability to provide informed consent.
  • Establish medical care within the Ochsner System to facilitate data collection.

Exclusion criteria

  • History of preeclampsia or gestational hypertension during previous pregnancy
  • History of chronic hypertension
  • History of coronary artery disease (myocardial infarction, coronary stent placement, coronary artery bypass grafting, spontaneous coronary artery dissection)
  • History of ischemic CVA
  • History of Congestive heart failure
  • Renal dysfunction
  • Liver dysfunction
  • Left ventricular dysfunction
  • Congenital heart disease
  • Still birth at delivery

Treatment and study plan

video

Other

Those in the intervention arm will watch a short educational video.

Text Reminder

Other

Those in the intervention group will receive regular text message reminders to check their blood pressures

Blood pressure threshold

Other

Those in the intervention group will have a lower blood pressure threshold to titrate their BP medications towards

Primary outcomes

  1. Engagement

    Time frame: 6 weeks

    Engagement will be defined by frequency of use: number of remote BP measurements ascertained during the 6 week postpartum period.

  2. Acceptability

    Time frame: 6 weeks

    Post program survey questions using 5-item Likert response scale at 6 weeks postpartum

  3. Duration of Participation

    Time frame: 6 weeks

    Duration of participation is defined by the last day of recorded remote BP measurement

Secondary outcomes

  1. Post partum Blood pressure

    Time frame: 1 year

    Proportion of patients with BP <130/80 at 6 weeks Mean SBP, DBP at 6 weeks, 6 months, 1 year postpartum

  2. Number of ED visits

    Time frame: 1 year

    Number of ED visits recorded after discharge from her delivery encounter over the following year.

  3. Severe Maternal Morbidity

    Time frame: 1 year

    Incidence of death, postpartum stroke, congestive heart failure, myocardial infarction, eclampsia

  4. Number of Inpatient re-admissions

    Time frame: 1 year

    Number of inpatient re-admissions over the following year after discharge from delivery encounter

  5. Post partum visit follow up

    Time frame: 6 weeks

    Proportion of 4-6 week postpartum follow up visit attendance with OB provider

Study contacts

Contact information is provided by the study sponsor or research team.

Salima Qamruddin, MD

CONTACT

[email protected]

+1 (504) 842-4135

Sponsors and collaborators

Lead sponsor

Ochsner Health System

Other

Registry information

Official study title

Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education to Reduce Emergency Department Visits, Re-admissions and Adverse Cardiovascular Outcomes in Hypertensive Disorder of Pregnancy

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Apr 9, 2025
Registry last updated
Apr 9, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.